A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates Meeting Abstract
| Authors: | Choueiri, T. K.; Jacobus, S. J.; Qu, A. Q.; Sweeney, C.; Appleman, L. J.; Tretter, C. P. G.; Bubley, G. J.; Elfiky, A.; Park, R.; Stack, E. C.; Signoretti, S.; Walsh, M. K.; Steele, G.; Hirsch, M. S.; Krajewski, K. M.; Taplin, M. E.; Rosenberg, J. E.; Ross, R. W. |
| Abstract Title: | A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates |
| Meeting Title: | 2013 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2013 Feb 14-16 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-20 |
| Language: | English |
| ACCESSION: | WOS:000333679600278 |
| DOI: | 10.1200/jco.2013.31.6_suppl.278 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 278 -- Source: Wos |
